Liquid biopsies come of age: towards implementation of circulating tumour DNA

Nature Reviews Cancer 17, 223 (2017). doi:10.1038/nrc.2017.7 Authors: Jonathan C. M. Wan, Charles Massie, Javier Garcia-Corbacho, Florent Mouliere, James D. Brenton, Carlos Caldas, Simon Pacey, Richard Baird & Nitzan Rosenfeld Improvements in genomic and molecular methods are expanding the range of potential applications for circulating tumour DNA (ctDNA), both in a research setting and as a 'liquid biopsy' for cancer management. Proof-of-principle studies have demonstrated the translational potential of ctDNA for prognostication, molecular profiling and
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Tags: Review Source Type: research